Land: Australien
Språk: engelska
Källa: Department of Health (Therapeutic Goods Administration)
sennosides, Quantity: 13.3 mg (Equivalent: sennoside B, Qty 8 mg); docusate sodium, Quantity: 50 mg
Cipla Australia Pty Ltd
Docusate sodium,Sennosides
Tablet, film coated
Excipient Ingredients: microcrystalline cellulose; purified talc; maize starch; croscarmellose sodium; colloidal anhydrous silica; magnesium stearate; sodium benzoate; Shellac; white beeswax; industrial methylated spirit; Carnauba Wax; titanium dioxide; hypromellose; iron oxide red; macrogol 400
Oral
90, 200
Not scheduled. Not considered by committee
Faecal softener and stimulant laxative.
Visual Identification: Brown coloured, circular shaped, biconvex film coated tablet plain on both sides; Container Type: Bottle; Container Material: HDPE; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius
Licence status A
2016-03-01